Telix Pharmaceuticals Ratios (2023-2025) | TLX

Ratios Dec2023 Dec2024 Dec2025
Efficiency
Inventory Average (Quarter) 18.11M31.01M
Assets Average (Quarter) 627.98M
Invested Capital (Quarter) 126.66M373.29M405.02M
Leverage & Solvency
Debt Ratio (Quarter) 0.020.38
Valuation
Enterprise Value (Quarter) -80.23M-464.54M-141.87M